FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved a supplemental application for Omeprazole from Apotex Corp, confirming approval of a supplemental filing for this generic proton pump inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)